Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07159165Enrolling By Invitation

Registry of MIUS for Benign Prostatic Obstruction

Role: collaborator

NCT05797207Not ApplicableUnknown

Evaluation of the Diagnostic Potential of Artificial Intelligence-assisted Fecal Microbiome Testing for Inflammatory Bowel Disease

Role: collaborator

NCT05795725Not ApplicableUnknown

Evaluation of the Diagnostic Potential of Artificial Intelligence-assisted Fecal Microbiome Testing for Colon Cancer

Role: collaborator

NCT05351632Unknown

Comprehensive Complication Index in the Classification of Complications of Percutaneous Nephrolithotomy

Role: collaborator

All 4 trials loaded